Serveur d'exploration sur l'Indium - Analysis (France)

Index « Auteurs » - entrée « David M Goldenberg »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

List of bibliographic references

Number of relevant bibliographic references: 6

.
Ident.Authors (with country if any)Title
000022 (2012) Françoise Kraeber-Bodéré (France) ; Pierre-Yves Salaun ; Catherine Ansquer ; Delphine Drui ; Eric Mirallié ; Alain Faivre-Chauvet ; Jacques Barbet ; David M Goldenberg ; Jean-François ChatalPretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC).
000023 (2012) Pierre-Yves Salaun (France) ; Loïc Campion ; Claire Bournaud ; Alain Faivre-Chauvet ; Jean-Philippe Vuillez ; David Taieb ; Catherine Ansquer ; Caroline Rousseau ; Françoise Borson-Chazot ; Stéphane Bardet ; Aurore Oudoux ; Bertrand Cariou ; Eric Mirallié ; Chien-Hsing Chang ; Robert M Sharkey ; David M Goldenberg ; Jean-François Chatal ; Jacques Barbet ; Françoise Kraeber-BodéréPhase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.
000094 (2006) Françoise Kraeber-Bodéré (France) ; Caroline Rousseau ; Caroline Bodet-Milin ; Ludovic Ferrer ; Alain Faivre-Chauvet ; Loïc Campion ; Jean-Philippe Vuillez ; Anne Devillers ; Chien-Hsing Chang ; David M Goldenberg ; Jean-François Chatal ; Jacques BarbetTargeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial.
000095 (2006) Jean-François Chatal (France) ; Loïc Campion ; Françoise Kraeber-Bodéré ; Stephane Bardet ; Jean-Philippe Vuillez ; Bernard Charbonnel ; Vincent Rohmer ; Chien-Hsing Chang ; Robert M Sharkey ; David M Goldenberg ; Jacques Barbet ; Survival improvement in patients with medullary thyroid carcinoma who undergo pretargeted anti-carcinoembryonic-antigen radioimmunotherapy: a collaborative study with the French Endocrine Tumor Group.
000116 (2005) Eric Mirallié (France) ; Catherine Saï-Maurel ; Alain Faivre-Chauvet ; Nicolas Regenet ; Chien-Hsing Chang ; David M Goldenberg ; Jean-François Chatal ; Jacques Barbet ; Philippe ThedrezImproved pretargeted delivery of radiolabelled hapten to human tumour xenograft in mice by avidin chase of circulating bispecific antibody.
000129 (2003) Françoise Kraeber-Bodéré (France) ; Alain Faivre-Chauvet ; Ludovic Ferrer ; Jean-Philippe Vuillez ; Pierre-Yves Brard ; Caroline Rousseau ; Isabelle Resche ; Anne Devillers ; Sophie Laffont ; Manuel Bardiès ; Ken Chang ; Robert M Sharkey ; David M Goldenberg ; Jean-François Chatal ; Jacques BarbetPharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial.

List of associated KwdEn.i

Nombre de
documents
Descripteur
6Humans
5Radioimmunotherapy (methods)
4Thyroid Neoplasms (radiotherapy)
3Adult
3Aged
3Animals
3Female
3Male
3Middle Aged
3Neoplasm Metastasis
2Antibodies, Bispecific (adverse effects)
2Iodine Radioisotopes (therapeutic use)
2Mice
2Prognosis
2Radioimmunotherapy (adverse effects)
2Survival Analysis
2Thyroid Neoplasms (diagnosis)
2Treatment Outcome
1Aged, 80 and over
1Antibodies (blood)
1Antibodies (immunology)
1Antibodies (therapeutic use)
1Antibodies, Bispecific (administration & dosage)
1Antibodies, Bispecific (chemistry)
1Antibodies, Bispecific (pharmacokinetics)
1Antibodies, Bispecific (therapeutic use)
1Antibodies, Monoclonal (administration & dosage)
1Antibodies, Monoclonal (adverse effects)
1Antibodies, Monoclonal (therapeutic use)
1Antibodies, Monoclonal, Humanized (adverse effects)
1Antibodies, Monoclonal, Humanized (therapeutic use)
1Avidin (administration & dosage)
1Bone Marrow (pathology)
1Calcitonin (blood)
1Carcinoembryonic Antigen (blood)
1Carcinoembryonic Antigen (chemistry)
1Carcinoembryonic Antigen (immunology)
1Carcinoembryonic Antigen (therapeutic use)
1Carcinoma (metabolism)
1Carcinoma (radiotherapy)
1Cell Line, Tumor
1Colonic Neoplasms (metabolism)
1Colonic Neoplasms (radiotherapy)
1Combined Modality Therapy
1Disease Progression
1Dose Fractionation
1Drug Combinations
1Drug Delivery Systems (methods)
1Haptens (administration & dosage)
1Haptens (adverse effects)
1Haptens (chemistry)
1Indium (therapeutic use)
1Iodine Radioisotopes (administration & dosage)
1Iodine Radioisotopes (adverse effects)
1Iodine Radioisotopes (pharmacokinetics)
1Metabolic Clearance Rate (drug effects)
1Mice, Nude
1Neoplasms (therapy)
1Neoplasms, Experimental
1Organ Specificity (drug effects)
1Pentetic Acid
1Pentetic Acid (immunology)
1Protein Kinase Inhibitors (therapeutic use)
1Quality Control
1Radiation Injuries (diagnosis)
1Radiation Injuries (etiology)
1Radioimmunotherapy
1Radiometry
1Radiopharmaceuticals (administration & dosage)
1Radiopharmaceuticals (adverse effects)
1Radiotherapy Dosage
1Risk Assessment (methods)
1Thyroid Neoplasms (drug therapy)
1Thyroid Neoplasms (metabolism)
1Thyroid Neoplasms (mortality)
1Thyroid Neoplasms (pathology)
1Time Factors
1Tissue Distribution
1Tissue Distribution (drug effects)
1Tumor Markers, Biological (metabolism)
1Young Adult

Affichage en shell (Unix/Dilib)

IndexSelect -h IndiumV2/Data/France/Analysis/Author.i -k "David M Goldenberg" 
IndexSelect -h IndiumV2/Data/France/Analysis/Author.i  \
                -Sk "David M Goldenberg" \
         | HfdSelect -Kh IndiumV2/Data/France/Analysis/biblio.hfd 

Wicri

This area was generated with Dilib version V0.5.76.
Data generation: Tue May 20 07:24:43 2014. Site generation: Tue May 20 08:20:52 2014